Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Processa Pharmaceuticals, Inc.

PCSA · Nasdaq · CIK 0001533743 · Healthcare · Biotechnology

INSIDER SIGNAL

68.4 / 100

6 buyers · 27 purchase transaction lines · $135.4K gross purchase

WHY THIS SIGNAL?

Buyer breadthStrong
Purchase sizeLow
RoleModerate
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+35.0 / 35
Purchase size+8.8 / 25
Role+13.0 / 20
Recency+1.6 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ Role scores low · most senior buyer: Chief Executive Officer (CEO, chair and 10% owners score lowest)
  • ⚠ Purchase activity is becoming less recent
  • ✓ Cluster breadth is broad · 4+ insiders

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Ng George KChief Executive Officer
●●●●●○
Young DavidPres. Research & Development
●●●●●
SKIBSTED RUSSELLChief Financial Officer
●●●●●
Lin PatrickChief Business - Strategy Off
●●●●●
Guy WendyChief Administrative Officer
●●●●●
Bigora SianChief Development Officer
●●
● Purchase▼ Sale○ Other

Showing the six most active owners; 4 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS6
PURCHASE CONCENTRATION22%Largest buyer: SKIBSTED RUSSELL · $29.9K
CLUSTER BUYING · 15D6 insidersPeak activity: 2026-04-30–2026-05-15

Roles in the peak window: Chief Administrative Officer, Chief Business - Strategy Off, Chief Development Officer, Chief Executive Officer, Chief Financial Officer, Pres. Research & Development. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

68.4 / 100

Latest recorded score

→ +0.0 ptsversus the previous recorded snapshot
  1. 68.6
  2. 68.5
  3. 68.5
  4. 68.4
  5. 68.4

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

35Purchases
0Sales
9Other Form 4 lines
44SEC filings · 365 days
BUYING27 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER5 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-17.8%
3M
-26.2%
6M
-45.1%
12M
-87.3%

Volatility & liquidity

Volatility
153.1%
Beta
—
Avg daily value
USD 414,943

Valuation

Market cap
USD 4.2M
P/E
—

Fundamentals

Profit margin
—
ROE
-243.2%
Industry
Biotechnology

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-07 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
4,140
Previous report
14,995
Avg daily volume
23,095
Days to cover
≤ 1.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-07-01Ng George KPurchase (P)Common Stock3,057USD 1.93USD 5,900SEC filing ↗
2026-06-30Young DavidPurchase (P)Common Stock2,531USD 1.93USD 4,885SEC filing ↗
2026-06-30SKIBSTED RUSSELLPurchase (P)Common Stock3,277USD 1.93USD 6,325SEC filing ↗
2026-06-30Lin PatrickPurchase (P)Common Stock2,106USD 1.93USD 4,065SEC filing ↗
2026-06-30Guy WendyPurchase (P)Common Stock2,436USD 1.93USD 4,701SEC filing ↗
2026-06-15Young DavidPurchase (P)Common Stock2,067USD 2.22USD 4,589SEC filing ↗
2026-06-15SKIBSTED RUSSELLPurchase (P)Common Stock2,654USD 2.22USD 5,892SEC filing ↗
2026-06-15Ng George KPurchase (P)Common Stock2,465USD 2.22USD 5,472SEC filing ↗
2026-06-15Lin PatrickPurchase (P)Common Stock1,831USD 2.22USD 4,065SEC filing ↗
2026-06-15Guy WendyPurchase (P)Common Stock2,118USD 2.22USD 4,702SEC filing ↗
2026-05-29Young DavidPurchase (P)Common Stock1,786USD 2.57USD 4,590SEC filing ↗
2026-05-29SKIBSTED RUSSELLPurchase (P)Common Stock2,292USD 2.57USD 5,890SEC filing ↗
2026-05-29Ng George KPurchase (P)Common Stock2,129USD 2.57USD 5,472SEC filing ↗
2026-05-29Lin PatrickPurchase (P)Common Stock1,582USD 2.57USD 4,066SEC filing ↗
2026-05-29Guy WendyPurchase (P)Common Stock1,829USD 2.57USD 4,701SEC filing ↗

Form 4 evidence

44 transaction lines in the latest 365-day window; 190 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-08Ng George KOption exercise / conversion (M)Common Stock1,600USD —USD —SEC filing ↗
2026-07-01Ng George KPurchase (P)Common Stock3,057USD 1.93USD 5,900SEC filing ↗
2026-06-30Young DavidPurchase (P)Common Stock2,531USD 1.93USD 4,885SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-08Ng George KOption exercise / conversion (M)Common Stock1,600USD —USD —SEC filing ↗
2026-07-01Ng George KPurchase (P)Common Stock3,057USD 1.93USD 5,900SEC filing ↗
2026-06-30Young DavidPurchase (P)Common Stock2,531USD 1.93USD 4,885SEC filing ↗
2026-06-30SKIBSTED RUSSELLPurchase (P)Common Stock3,277USD 1.93USD 6,325SEC filing ↗
2026-06-30Lin PatrickPurchase (P)Common Stock2,106USD 1.93USD 4,065SEC filing ↗
2026-06-30Guy WendyPurchase (P)Common Stock2,436USD 1.93USD 4,701SEC filing ↗
2026-06-26Yorke Justin WOption exercise / conversion (M)Common Stock203USD —USD —SEC filing ↗
2026-06-26Pannu GeraldineOption exercise / conversion (M)Common Stock203USD —USD —SEC filing ↗
2026-06-26Neal James ROption exercise / conversion (M)Common Stock203USD —USD —SEC filing ↗
2026-06-26Baluch KhosoOption exercise / conversion (M)Common Stock203USD —USD —SEC filing ↗
2026-06-15Young DavidPurchase (P)Common Stock2,067USD 2.22USD 4,589SEC filing ↗
2026-06-15SKIBSTED RUSSELLPurchase (P)Common Stock2,654USD 2.22USD 5,892SEC filing ↗
2026-06-15Ng George KPurchase (P)Common Stock2,465USD 2.22USD 5,472SEC filing ↗
2026-06-15Lin PatrickPurchase (P)Common Stock1,831USD 2.22USD 4,065SEC filing ↗
2026-06-15Guy WendyPurchase (P)Common Stock2,118USD 2.22USD 4,702SEC filing ↗
2026-05-29Young DavidPurchase (P)Common Stock1,786USD 2.57USD 4,590SEC filing ↗
2026-05-29SKIBSTED RUSSELLPurchase (P)Common Stock2,292USD 2.57USD 5,890SEC filing ↗
2026-05-29Ng George KPurchase (P)Common Stock2,129USD 2.57USD 5,472SEC filing ↗
2026-05-29Lin PatrickPurchase (P)Common Stock1,582USD 2.57USD 4,066SEC filing ↗
2026-05-29Guy WendyPurchase (P)Common Stock1,829USD 2.57USD 4,701SEC filing ↗
2026-05-15Young DavidPurchase (P)Common Stock1,545USD 2.97USD 4,589SEC filing ↗
2026-05-15SKIBSTED RUSSELLPurchase (P)Common Stock1,984USD 2.97USD 5,892SEC filing ↗
2026-05-15Ng George KPurchase (P)Common Stock1,843USD 2.97USD 5,474SEC filing ↗
2026-05-15Lin PatrickPurchase (P)Common Stock1,369USD 2.97USD 4,066SEC filing ↗
2026-05-15Guy WendyPurchase (P)Common Stock1,583USD 2.97USD 4,702SEC filing ↗
2026-04-30Bigora SianPurchase (P)Common Stock1,971USD 2.71USD 5,341SEC filing ↗
2026-04-30Young DavidPurchase (P)Common Stock1,706USD 2.69USD 4,589SEC filing ↗
2026-04-30SKIBSTED RUSSELLPurchase (P)Common Stock2,190USD 2.69USD 5,891SEC filing ↗
2026-04-30Ng George KPurchase (P)Common Stock2,034USD 2.69USD 5,471SEC filing ↗
2026-04-30Lin PatrickPurchase (P)Common Stock1,511USD 2.69USD 4,065SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerPCSA
CIK0001533743
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history190 transaction lines from 2020-10-01 to 2026-08-08
66 P purchase lines · 17 S sale lines · 107 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.